×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ALZN – alzamend neuro, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ALZN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/20
08:05 am
alzn
Alzamend Neuro Receives FDA "Study May Proceed" Notification for a Phase IIA Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, in Major Depressive Disorder Patients [Yahoo! Finance]
High
Report
Alzamend Neuro Receives FDA "Study May Proceed" Notification for a Phase IIA Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, in Major Depressive Disorder Patients [Yahoo! Finance]
11/20
08:00 am
alzn
Alzamend Neuro Receives FDA “Study May Proceed” Notification for a Phase IIA Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, in Major Depressive Disorder Patients
High
Report
Alzamend Neuro Receives FDA “Study May Proceed” Notification for a Phase IIA Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, in Major Depressive Disorder Patients
11/16
08:20 am
alzn
Alzamend Neuro Regains Compliance with Nasdaq's Minimum Bid Price Requirement [Yahoo! Finance]
Low
Report
Alzamend Neuro Regains Compliance with Nasdaq's Minimum Bid Price Requirement [Yahoo! Finance]
11/16
08:00 am
alzn
Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
Low
Report
Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
11/13
08:19 am
alzn
Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Post-Traumatic Stress Disorder Patients of Next-Generation Lithium Therapeutic Drug Candidate AL001 [Yahoo! Finance]
High
Report
Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Post-Traumatic Stress Disorder Patients of Next-Generation Lithium Therapeutic Drug Candidate AL001 [Yahoo! Finance]
11/13
08:00 am
alzn
Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Post-Traumatic Stress Disorder Patients of Next-Generation Lithium Therapeutic Drug Candidate AL001
High
Report
Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Post-Traumatic Stress Disorder Patients of Next-Generation Lithium Therapeutic Drug Candidate AL001
10/30
08:00 am
alzn
Alzamend Neuro Announces Reverse Stock Split
High
Report
Alzamend Neuro Announces Reverse Stock Split
10/23
09:42 am
alzn
EXCLUSIVE: Alzamend Neuro Submits IND For Phase IIA Trial Of Next-Gen Lithium Candidate In Major Depressive Disorder [Yahoo! Finance]
Low
Report
EXCLUSIVE: Alzamend Neuro Submits IND For Phase IIA Trial Of Next-Gen Lithium Candidate In Major Depressive Disorder [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/16
04:31 pm
alzn
Form 8-K Alzamend Neuro, Inc. For: Nov 16
High
Report
Form 8-K Alzamend Neuro, Inc. For: Nov 16
9/29
04:42 pm
alzn
Form 8-K Alzamend Neuro, Inc. For: Sep 29
Medium
Report
Form 8-K Alzamend Neuro, Inc. For: Sep 29
9/26
06:02 pm
alzn
Form 4 Alzamend Neuro, Inc. For: Sep 26 Filed by: Katzoff David J
High
Report
Form 4 Alzamend Neuro, Inc. For: Sep 26 Filed by: Katzoff David J
9/22
04:31 pm
alzn
Form 8-K Alzamend Neuro, Inc. For: Sep 22
Medium
Report
Form 8-K Alzamend Neuro, Inc. For: Sep 22
9/13
05:10 pm
alzn
Form 10-Q Alzamend Neuro, Inc. For: Jul 31
Medium
Report
Form 10-Q Alzamend Neuro, Inc. For: Jul 31
9/8
05:05 pm
alzn
Form 424B5 Alzamend Neuro, Inc.
Medium
Report
Form 424B5 Alzamend Neuro, Inc.
9/8
05:01 pm
alzn
Form 8-K Alzamend Neuro, Inc. For: Sep 08
Medium
Report
Form 8-K Alzamend Neuro, Inc. For: Sep 08
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: